NIH-funded research R01 grant

Vaginal microbiota transplant to promote Lactobacillus-dominant cervicovaginal communities

Funded at Massachusetts General Hospital · NIH-11411247 · Data updated 2026-11-12

A clinical trial tests whether transferring vaginal microbiota from healthy donors can establish Lactobacillus-dominant vaginal communities to reduce risks linked with bacterial vaginosis.

More Microbiota research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionMassachusetts General Hospital
NIH-funded
Lab location1 site (Boston, United States)
Project startSeptember 20, 2021
Project endAugust 31, 2027
Funding year2026
Award (this year)$832,912
NIH project number5R01AI158836-05
Project IDNIH-11411247 on NIH RePORTER

Who could benefit from this research

Could help

Adults with a history of recurrent BV and an abnormal Nugent score who are willing to participate in donor screening and a randomized transplant trial.

Less likely to help

Individuals without BV history or those not meeting eligibility criteria may not benefit from this specific transplant intervention.

What this research studies

This study will enroll up to 25 healthy donors and 126 recipients with a history of recurrent BV. After a short course of metronidazole, recipients are randomized to receive a vaginal microbiota transplant or a saline placebo in two doses within one week. The research includes extensive testing of donors, transplant material, and recipient microbiota to understand how the transplanted community engrafts and remains stable. The goal is to identify factors that promote lasting, healthy vaginal bacterial communities and reduce related health risks. Participants will be monitored for safety and changes in the vaginal microbiome over time.

Why it matters

Potential benefit: If successful, this approach could lead to a durable shift toward healthy, Lactobacillus-dominant vaginal microbiota and lower risk of BV-related complications.

How similar studies have gone: Preliminary data suggest stability of donated Lactobacillus in transplant material, supporting potential success for this strategy.

Where this research is happening

  • Massachusetts General Hospital
    Boston, United States
    Active

Researchers

  • Principal investigator: Mitchell, Caroline M — Massachusetts General Hospital
  • Study coordinator: Mitchell, Caroline M

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.